Skip to main content

Gilead Joining the Global Access to Oncology Medicines Coalition

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

We’re pleased to announce that we're joining the global Access to Oncology Medicines (ATOM) Coalition to help improve care and access to essential cancer medicines in low- and lower middle-income countries. https://gilead.inc/39Gb9nb

About Gilead

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

View original content here

Tweet me: .@GileadSciences announces they are joining the global Access to Oncology Medicines (ATOM) Coalition. Read more here: https://bit.ly/3PHkf3F

KEYWORDS: NYSE: GILD, Gilead Sciences, ATOM

"Making strides against cancer in low- and lower middle- income countries will require not only innovative therapies, but also bold strategies built on the power of partnerships and working across the continuum of care - starting from disease awareness and prevention, to diagnosis and treatment, all the way to disease management." Mike Boyd Senior Vice President Gilead logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  200.12
+1.33 (0.67%)
AAPL  261.49
+5.71 (2.23%)
AMD  202.35
-4.97 (-2.40%)
BAC  52.78
+0.23 (0.44%)
GOOG  301.82
-4.20 (-1.37%)
META  637.00
-2.77 (-0.43%)
MSFT  396.98
-4.34 (-1.08%)
NVDA  184.44
+1.63 (0.89%)
ORCL  154.27
-5.87 (-3.67%)
TSLA  405.93
-11.51 (-2.76%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.